Tonix Pharmaceuticals Files 2024 10-K
Ticker: TNXP · Form: 10-K · Filed: Mar 18, 2025 · CIK: 1430306
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Tonix Pharma filed its 2024 10-K. Check financials.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed its 2024 10-K on March 18, 2025, reporting its financial results for the fiscal year ending December 31, 2024. The company, incorporated in Nevada, operates in the pharmaceutical preparations sector. Its principal executive offices are located at 26 Main Street, Suite 101, Chatham, NJ 07928.
Why It Matters
This filing provides investors with a comprehensive overview of Tonix Pharmaceuticals' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Tonix is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-18 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-18 (date) — Filing date
- 26 Main Street, Suite 101, Chatham, NJ 07928 (address) — Business and mailing address
FAQ
What is the primary business of Tonix Pharmaceuticals Holding Corp.?
Tonix Pharmaceuticals Holding Corp. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code 2834.
When did Tonix Pharmaceuticals Holding Corp. change its former name?
The company formerly known as TAMANDARE EXPLORATIONS INC. changed its name on March 20, 2008.
What is the state of incorporation for Tonix Pharmaceuticals Holding Corp.?
Tonix Pharmaceuticals Holding Corp. is incorporated in Nevada (NV).
What is the SEC file number for Tonix Pharmaceuticals Holding Corp.?
The SEC file number for Tonix Pharmaceuticals Holding Corp. is 001-36019.
What is the fiscal year end for Tonix Pharmaceuticals Holding Corp.?
The fiscal year end for Tonix Pharmaceuticals Holding Corp. is December 31 (1231).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 18, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).